ClinicalTrials.gg
Not yet recruitingNCT07391969Updated Feb 6, 2026

Evaluation of SaCo VLMA for General Anesthesia for Laparoscopic Procedures

An interventional study of SaCo VLM or SAD or ET for airway control for laparoscopy in Laparoscopic Surgical Procedures, Airway Control and Anesthesia, sponsored by Medical University of Lodz. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-06.

Sponsored by Medical University of Lodz · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Evaluation of new supraglottic device SaCo VLMA for laparoscopic procedures under general anesthesia in comparison with other airway management methods including other supraglottic devices. The parameters noted will be: demographic data, time for placement of SGA counted from moment of grabbing device by operator to correct placement, subjective evaluation of ease of insertion of SGA in 5 step Borg scale, peak pressure, lung compliance, achieved tidal volume before creating pneumoperitoneum, after creating pneumoperitoneum, visualization of glottis on monitor of camera or fiberoptic scope.

Read the detailed description

Evaluation of new supraglottic device SaCo VLMA for laparoscopic procedures under general anesthesia in comparison of other supraglottic devices and other methods of airway management for such procedures.

The airway management for laparoscopic surgery can be achieved by either endotracheal intubation (ET) or use of supraglottic devices (SGA). However, many anesthesiologist still prefer ET over use of SGA because of possible problems with adequate ventilation during pneumoperitoneum.

New SGA devices as video laryngeal mask offer important advantage which is continuous control of proper placement of SGA during anesthesia. In case of ventilation difficulties like leak, high peak pressure, low tidal volume SGA VLM allow to check if the problem is related to malposition or changed of position of SGA and allow for correction under control of vision.

The aim of this study is to evaluate the characteristics of the SaCo VLMA video laryngeal mask in the hands of experienced anesthesiologists.

All patients will be anesthetized following the same protocol: Intravenous induction with propofol, FNT, midazolam, rocuronium in standard doses. After achieving proper muscle relaxation SaCo VLMA was inserted following manufacturer recommendations. For maintaining anesthesia sevoflurane was used.

After induction for anesthesia the airway of the patient will be secured by one randomly chosen device: SaCo VLMA or other SGA or ET.

The parameters noted will be: demographic data, time for placement of SGA counted from moment of grabbing device by operator to correct placement, subjective evaluation of ease of insertion of SGA in 5 step Borg scale, peak pressure, lung compliance, achieved tidal volume before creating pneumoperitoneum, after creating pneumoperitoneum, visualization of glottis on monitor of camera or fiberoptic scope.

02

Conditions studied

  • Laparoscopic Surgical Procedures
  • Airway Control
  • Anesthesia
03

In context

Lead sponsor

Medical University of Lodz is the lead sponsor of 107 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing elective surgery under general anesthesia for laparoscopic surgery of predicting lasting no longer than about 1 hour.
  • Age >18 years.
  • .
  • Present ordinary airway

Exclusion criteria

Exclusion Criteria:

  • Not meeting the above criteria
  • Presenting 3 predictors of a difficult airway (Mallampatti class III or IV; thyromental distance \<6 cm, sternomental distance \<12.5 cm, distance between incisors \<4.0 cm, bite test II or III, cervical mobility \<90o).
  • Gestation
  • Allergy to any drug included in the protocol.
  • Present risk factors for bronchial aspiration

    - Presenting with preoperative sore throat

  • Present severe respiratory, coronary or cerebral vascular pathology.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    SaCo VLMA airway management

    SaCo VLMA Supraglottic Airway Device for airway control in anesthetized patient for general anesthesia for laparoscopic surgery

    Device: SaCo VLM or SAD or ET for airway control for laparoscopy

  • Active comparator
    Other device for airway management

    Other Airway Device for airway control in anesthetized patient for general anesthesia for laparoscopic surgery

    Device: SaCo VLM or SAD or ET for airway control for laparoscopy

Interventions

  • DeviceSaCo VLM or SAD or ET for airway control for laparoscopy

    Evaluation of the new SGAs for airway control in anesthetized patients for laparoscopy procedures

06

What researchers measure

Primary outcomes

  1. effectiveness of use

    success ratio of insertion of SGA or ET in % of success insertion

    Time frame: immediately after the intervention

  2. effectiveness of mechanical ventilation

    adequate ventilation described as maintaining adequate minute ventilation with acceptable leak in Tidal Volume in ml

    Time frame: perioperatively

  3. safety of mechanical ventilation

    providing adequate ventilation parameters - peak pressure in mmHg

    Time frame: perioperatively

  4. parameters of mechanical ventilation

    measurement of lung compliance in ml/mmHg

    Time frame: perioperatively

Secondary outcomes

  1. safety of use of SaCo VLM

    complications ratio related to airway management in %

    Time frame: immediately after the surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Feb 2026; primary completion for Jan 2027, 11 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2026
First posted
Feb 6, 2026
StartEst.
Feb 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Mar 1, 2027
Last update
Feb 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07391969
Responsible party
Tomasz Gaszynski (prof. dr hab., Medical University of Lodz) — Principal investigator
First posted
Feb 6, 2026
Start date
Feb 1, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Feb 6, 2026

Study contacts

Tomasz Gaszynski
Contact
tomasz.gaszynski@umed.lodz.pl
693462098 ext. +48
Paweł Ratajczyk
Contact
pawel.ratajczyk@umed.lodz.pl
693462098 ext. +48
Tomasz Gaszynski
principal investigator · Medical University of Lodz

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion